ClinicalTrials.gov
ClinicalTrials.gov Menu

Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients (PICCO-LungT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00834054
Recruitment Status : Completed
First Posted : February 3, 2009
Last Update Posted : September 23, 2016
Sponsor:
Information provided by (Responsible Party):
Hopital Foch

Brief Summary:
Repeated measurements of lung water by single transpulmonary thermodilution during the first postoperative days following lung transplantation

Condition or disease Intervention/treatment
Mucoviscidosis Pulmonary Insufficiency Procedure: Double-lung transplantation

Study Type : Observational
Estimated Enrollment : 15 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interest of Repeated Extravascular Lung Water Measurements With the PICCO Device in Lung Transplanted Patients
Study Start Date : January 2009
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Double-lung transplanted patients Procedure: Double-lung transplantation
Double-lung transplanted patients




Primary Outcome Measures :
  1. extra-vascular lung water [ Time Frame: first postoperative days ]

Secondary Outcome Measures :
  1. pulmonary permeability index [ Time Frame: first postoperative days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
double-lung transplanted patients
Criteria

Inclusion Criteria:

  • double-lung transplanted patients

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00834054


Locations
France
Hopital Foch
Suresnes, France, 92150
Sponsors and Collaborators
Hopital Foch
Investigators
Study Chair: Charles Cerf, MD Hopital Foch

Responsible Party: Hopital Foch
ClinicalTrials.gov Identifier: NCT00834054     History of Changes
Other Study ID Numbers: 2008/18
First Posted: February 3, 2009    Key Record Dates
Last Update Posted: September 23, 2016
Last Verified: September 2016

Additional relevant MeSH terms:
Cystic Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases